The BBX Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Jurkat human T lymphocyte line, designed to disrupt BBX gene expression. This heterogeneous pool of cells harbors targeted gene disruptions introduced by CRISPR/Cas9, providing a loss-of-function model without clonal isolation. The polyclonal format maintains genetic diversity while eliminating BBX function, enabling robust phenotypic analysis. This model is suitable for dissecting BBX roles in T-cell leukemia and related signaling networks.
The parental Jurkat line is an immortalized human T lymphocyte line derived from acute T cell leukemia, growing in suspension as lymphoblasts. Extensively used to study T cell receptor signaling, apoptosis, and HIV infection, Jurkat cells possess constitutive activation of multiple pathways, including NF-??B and MAPK cascades. Their well-characterized transcriptional profile and genetic tractability make them an ideal host for CRISPR/Cas9-mediated gene disruption, allowing precise interrogation of gene function in a T-cell context.
BBX encodes an HMG-box transcription factor that regulates gene expression programs critical for cell cycle, differentiation, and development. It operates within the Wnt/??-catenin pathway, interacting with SOX2 and SOX10, ??-catenin, and TCF/LEF transcription factors to modulate target genes. BBX is activated downstream of WNT ligands and Frizzled receptors, and receives input from Notch signaling. Key downstream targets include CCND1, NES, and MYC, linking BBX to proliferation and stemness. Through chromatin modulation, BBX governs cell fate decisions in neural stem cells and potentially in leukemic lymphoblasts.
In Jurkat cells, BBX disruption offers a relevant model to explore its contributions to T-cell acute lymphoblastic leukemia. Aberrant Wnt/??-catenin signaling is implicated in this malignancy, and BBX may mediate transcriptional effects that promote leukemic growth and survival. Studying BBX loss in this polyclonal population allows examination of apoptosis, cell cycle dysregulation, and maintenance of an undifferentiated state. This system also facilitates investigation of Wnt-Notch crosstalk and comparisons with medulloblastoma and neurodevelopmental disorders where BBX is disrupted.
Applications include RT-qPCR and RNA-seq for gene expression analysis, co-immunoprecipitation and ChIP-qPCR for protein-DNA interactions, and flow cytometry for apoptosis and cell cycle. Luciferase reporter assays can measure Wnt/??-catenin activity, and western blotting validates downstream targets. This model supports functional studies in T-cell leukemia signaling, medulloblastoma, and stem cell biology. For more details or customized experimental approaches, please contact Ascent Research.
